This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Aladdin Healthcare Technologies Yönetim
Yönetim kriter kontrolleri 1/4
We currently do not have sufficient information about the CEO.
Anahtar bilgiler
Wade Menpes-Smith
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | no data |
| CEO sahipliği | 14.8% |
| Yönetim ortalama görev süresi | Veri yok |
| Yönetim Kurulu ortalama görev süresi | 4.1yrs |
Son yönetim güncellemeleri
Recent updates
CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2021 | n/a | n/a | €12k |
| Mar 31 2021 | n/a | n/a | -€610k |
| Dec 31 2020 | n/a | n/a | -€1m |
| Sep 30 2020 | n/a | n/a | -€2m |
| Jun 30 2020 | n/a | n/a | -€3m |
| Mar 31 2020 | n/a | n/a | -€3m |
| Dec 31 2019 | €137k | €100k | -€3m |
| Sep 30 2019 | n/a | n/a | -€4m |
| Jun 30 2019 | n/a | n/a | -€4m |
| Mar 31 2019 | n/a | n/a | -€4m |
| Dec 31 2018 | €205k | €170k | -€5m |
Tazminat ve Piyasa: Insufficient data to establish whether Wade's total compensation is reasonable compared to companies of similar size in the German market.
Tazminat ve Kazançlar: Insufficient data to compare Wade's compensation with company performance.
CEO
Wade Menpes-Smith
no data
Görev süresi
Mr. Wade Menpes-Smith serves as Chief Executive Officer, Managing Director & Chairman of the Board of Directors at Aladdin Healthcare Technologies SE (formerly known as Aladdin Blockchain Technologies Hold...
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman of the Board | no data | Veri yok | 14.8% € 39.9k | |
| Deputy Chairman & COO | no data | Veri yok | Veri yok | |
| CFO & Director | 2.3yrs | Veri yok | Veri yok | |
| Member of Drug Discovery Advisory Board & Chief Scientific Advisor | 2.4yrs | Veri yok | Veri yok | |
| Member of Early Diagnosis Advisory Board & Adviser of Early Stage Drug Discovery | 4.1yrs | Veri yok | Veri yok | |
| Member of Drug Advisory Board & Adviser of Neurological Research | 4.1yrs | Veri yok | Veri yok | |
| Member of Early Diagnosis Advisory Board & Adviser of Aging | 4.1yrs | Veri yok | Veri yok | |
| Member of Early Diagnosis Advisory Board & Adviser of Biological Research | 4.1yrs | Veri yok | Veri yok | |
| Member of Drug Advisory Board & Adviser of Cardiovascular | 4.1yrs | Veri yok | Veri yok | |
| Member of Drug Discovery Advisory Board & Adviser of Medical Imaging | 4.1yrs | Veri yok | Veri yok | |
| Member of Drug Discovery Advisory Board & Adviser of Biobank | 3.2yrs | Veri yok | Veri yok |
4.1yrs
Ortalama Görev Süresi
Deneyimli Yönetim Kurulu: NMI's board of directors are considered experienced (4.1 years average tenure).